Products and Applications
| The S.M.A.R.T. Facility is
equipped with two robotic platforms and other stand-alone instrumentation
that make feasible the development and implementation of a large array of
assay types, in either a 96- or 384-well format. The high level of
flexibility of this Facility also translates into the opportunity to
implement a variety of screening rationales, thanks to our robust
collection of libraries that include bioactives, FDA-approved drugs,
drug-like chemicals, semi-natural products and interference RNAs.
The Facility's personnel have a proven expertise in assay development, management of compounds for screening, lab automation and data storage/analysis, in addition to the scientific knowledge and the excellence in health research available throughout the Samuel Lunenfeld Research Institute. We are delighted to assist researchers in any steps necessary to perform experimental designs under high-throughput conditions, for either screening purposes or to dramatically expedite manual protocols which are routinely conducted on the bench. For high-throughput screening programs, we are available to discuss and professionally advise on the following, key aspects:
|